Cargando…
Drugs in Development for Malaria
The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role. Resistance of Plasmodium falciparum to the artemisinin derivatives, piperaquine and mefloquine in Southeast Asia means new antimalarials are needed with some urgency....
Autores principales: | Ashley, Elizabeth A., Phyo, Aung Pyae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013505/ https://www.ncbi.nlm.nih.gov/pubmed/29802605 http://dx.doi.org/10.1007/s40265-018-0911-9 |
Ejemplares similares
-
Clinical impact of vivax malaria: A collection review
por: Phyo, Aung Pyae, et al.
Publicado: (2022) -
Drugs in Development for Hepatitis B
por: Dawood, Altaf, et al.
Publicado: (2017) -
MicroRNA: Potential Targets for the Development of Novel Drugs?
por: Wu, Wei
Publicado: (2012) -
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020) -
Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy
por: Shorrock, Hannah K., et al.
Publicado: (2018)